Piribedil-d8 is a deuterated form of piribedil, a compound primarily used in the treatment of Parkinson's disease and other movement disorders. As a deuterated compound, Piribedil-d8 contains deuterium atoms, which are isotopes of hydrogen, replacing some of the hydrogen atoms in the original piribedil structure. This modification can enhance the stability and metabolic profile of the compound, making it useful in pharmacokinetic studies and research applications. Piribedil itself acts as a dopamine receptor agonist, influencing dopaminergic pathways in the brain, which is crucial for managing symptoms associated with dopamine deficiency. The deuteration may also improve the compound's solubility and bioavailability. In terms of physical properties, deuterated compounds often exhibit altered spectroscopic characteristics, which can be advantageous in analytical chemistry and drug development. Overall, Piribedil-d8 serves as a valuable tool in both clinical and research settings, particularly in understanding the pharmacodynamics and pharmacokinetics of dopaminergic therapies.

Piribedil-d8

1398044-45-5: Piribedil-d8 is a deuterated form of piribedil, a compound primarily used in the treatment of Parkinson's disease and other movement disorders. As a deuterated compound, Piribedil-d8 contains deuterium atoms, which are isotopes of hydrogen, replacing some of the hydrogen atoms in the original piribedil structure. This modification can enhance the stability and metabolic profile of the compound, making it useful in pharmacokinetic studies and research applications. Piribedil itself acts as a dopamine receptor agonist, influencing dopaminergic pathways in the brain, which is crucial for managing symptoms associated with dopamine deficiency. The deuteration may also improve the compound's solubility and bioavailability. In terms of physical properties, deuterated compounds often exhibit altered spectroscopic characteristics, which can be advantageous in analytical chemistry and drug development. Overall, Piribedil-d8 serves as a valuable tool in both clinical and research settings, particularly in understanding the pharmacodynamics and pharmacokinetics of dopaminergic therapies.

Piribedil D8 is the deuterium labeled Piribedil, which is an agent of antiparkinsonian.

CAS 1398044-45-5

Piribedil-d8

Piribedil-d8

Ref: 4Z-P-104003

Piribedil D8

Ref: TM-T12486

Piribedil-D₈

Ref: TR-P508752